Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS PROCTER & GAMBLE HEALTH IPCA LABS/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 51.7 34.5 150.1% View Chart
P/BV x 5.4 10.5 51.1% View Chart
Dividend Yield % 0.3 2.0 16.0%  

Financials

 IPCA LABS   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    IPCA LABS
Mar-23
PROCTER & GAMBLE HEALTH
Jun-23
IPCA LABS/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs1,0625,366 19.8%   
Low Rs7683,883 19.8%   
Sales per share (Unadj.) Rs243.0740.7 32.8%  
Earnings per share (Unadj.) Rs19.4138.2 14.0%  
Cash flow per share (Unadj.) Rs29.7155.2 19.1%  
Dividends per share (Unadj.) Rs4.0095.00 4.2%  
Avg Dividend yield %0.42.1 21.3%  
Book value per share (Unadj.) Rs230.3447.6 51.4%  
Shares outstanding (eoy) m253.7016.60 1,528.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.86.2 60.3%   
Avg P/E ratio x47.233.5 141.1%  
P/CF ratio (eoy) x30.829.8 103.4%  
Price / Book Value ratio x4.010.3 38.5%  
Dividend payout %20.668.7 30.0%   
Avg Mkt Cap Rs m232,12076,761 302.4%   
No. of employees `000NANA-   
Total wages/salary Rs m12,8762,062 624.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m61,64212,296 501.3%  
Other income Rs m1,518184 825.3%   
Total revenues Rs m63,16012,480 506.1%   
Gross profit Rs m9,0333,247 278.2%  
Depreciation Rs m2,616281 930.8%   
Interest Rs m4828 6,258.4%   
Profit before tax Rs m7,4533,142 237.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,534847 299.0%   
Profit after tax Rs m4,9192,295 214.4%  
Gross profit margin %14.726.4 55.5%  
Effective tax rate %34.027.0 126.1%   
Net profit margin %8.018.7 42.8%  
BALANCE SHEET DATA
Current assets Rs m51,89311,713 443.0%   
Current liabilities Rs m18,0586,791 265.9%   
Net working cap to sales %54.940.0 137.1%  
Current ratio x2.91.7 166.6%  
Inventory Days Days51263 19.5%  
Debtors Days Days6343 1.7%  
Net fixed assets Rs m34,33610,617 323.4%   
Share capital Rs m254166 152.8%   
"Free" reserves Rs m58,1677,265 800.7%   
Net worth Rs m58,4207,431 786.2%   
Long term debt Rs m6,5180-   
Total assets Rs m86,22922,330 386.2%  
Interest coverage x16.5409.1 4.0%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.70.6 129.8%   
Return on assets %6.310.3 60.7%  
Return on equity %8.430.9 27.3%  
Return on capital %12.242.4 28.8%  
Exports to sales %42.90-   
Imports to sales %13.313.1 101.6%   
Exports (fob) Rs m26,434NA-   
Imports (cif) Rs m8,1781,605 509.4%   
Fx inflow Rs m26,4341,465 1,804.1%   
Fx outflow Rs m8,1781,605 509.4%   
Net fx Rs m18,257-140 -13,021.9%   
CASH FLOW
From Operations Rs m8,0582,360 341.4%  
From Investments Rs m-7,250-215 3,372.1%  
From Financial Activity Rs m5,072-985 -515.1%  
Net Cashflow Rs m5,8811,160 506.8%  

Share Holding

Indian Promoters % 46.3 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 44.8 20.3 221.1%  
FIIs % 10.3 7.6 135.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 48.2 111.5%  
Shareholders   82,809 56,730 146.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on IPCA Labs vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IPCA Labs vs Procter & Gamble Health Share Price Performance

Period IPCA Labs Procter & Gamble Health S&P BSE HEALTHCARE
1-Day 3.35% -0.55% 1.18%
1-Month 4.27% -7.47% -0.75%
1-Year 56.49% -3.02% 61.82%
3-Year CAGR 9.46% -9.12% 18.16%
5-Year CAGR 20.88% 5.75% 19.79%

* Compound Annual Growth Rate

Here are more details on the IPCA Labs share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of IPCA Labs hold a 46.3% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IPCA Labs and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, IPCA Labs paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 20.6%.

Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.

You may visit here to review the dividend history of IPCA Labs, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.